MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cell.2024.06.015

Медицинская библиотека · Cell · 2024

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.

Barrett Jordan R, Pipini Dimitra, Wright Nathan D, Cooper Andrew J R, Gorini Giacomo, Quinkert Doris, Lias Amelia M, Davies Hannah, Rigby Cassandra A, Aleshnick Maya, Williams Barnabas G, Bradshaw William J, Paterson Neil G, Martinson Thomas, Kirtley Payton, Picard Luc, Wiggins Christine D, Donnellan Francesca R, King Lloyd D W, Wang Lawrence T, Popplewell Jonathan F, Silk Sarah E, de Ruiter Swain Jed, Skinner Katherine, Kotraiah Vinayaka, Noe Amy R, MacGill Randall S, King C Richter, Birkett Ashley J, Soisson Lorraine A, Minassian Angela M, Lauffenburger Douglas A, Miura Kazutoyo, Long Carole A, Wilder Brandon K, Koekemoer Lizbé, Tan Joshua, Nielsen Carolyn M, McHugh Kirsty, Draper Simon J

СтатьяПеревод пока не подготовлен

Аннотация

The highly conserved and essential Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has emerged as the leading target for vaccines against the disease-causing blood stage of malaria. However, the features of the human vaccine-induced antibody response that confer highly potent inhibition of malaria parasite invasion into red blood cells are not well defined. Here, we characterize 236 human IgG monoclonal antibodies, derived from 15 donors, induced by the most advanced PfRH5 vaccine. We define the antigenic landscape of this molecule and establish that epitope specificity, antibody association rate, and intra-PfRH5 antibody interactions are key determinants of functional anti-parasitic potency. In addition, we identify a germline IgG gene combination that results in an exceptionally potent class of antibody and demonstrate its prophylactic potential to protect against P. falciparum parasite challenge in vivo. This comprehensive dataset provides a framework to guide rational design of next-generation vaccines and prophylactic antibodies to protect against blood-stage malaria.

Для цитирования: Barrett Jordan R, Pipini Dimitra, Wright Nathan D, Cooper Andrew J R, Gorini Giacomo, Quinkert Doris, Lias Amelia M, Davies Hannah, Rigby Cassandra A, Aleshnick Maya, Williams Barnabas G, Bradshaw William J, Paterson Neil G, Martinson Thomas, Kirtley Payton, Picard Luc, Wiggins Christine D, Donnellan Francesca R, King Lloyd D W, Wang Lawrence T, Popplewell Jonathan F, Silk Sarah E, de Ruiter Swain Jed, Skinner Katherine, Kotraiah Vinayaka, Noe Amy R, MacGill Randall S, King C Richter, Birkett Ashley J, Soisson Lorraine A, Minassian Angela M, Lauffenburger Douglas A, Miura Kazutoyo, Long Carole A, Wilder Brandon K, Koekemoer Lizbé, Tan Joshua, Nielsen Carolyn M, McHugh Kirsty, Draper Simon J. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.. Cell. 2024. DOI: 10.1016/j.cell.2024.06.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.